Literature DB >> 21976257

Neurological Impairment Among Survivors of Intracerebral Hemorrhage: The FAST Trial.

Michael C Christensen1, Stephen Morris, Laura Vallejo-Torres, Catherine Vincent, Stephan A Mayer.   

Abstract

BACKGROUND: Intracerebral hemorrhage (ICH) is the deadliest and most disabling form of stroke. Little is known about the causes of persistent neurological impairment among ICH survivors.
METHODS: Factor seven for acute hemorrhagic stroke (FAST) was a randomized, multicenter, double-blind, placebo-controlled trial conducted at 122 sites in 22 countries. Neurological impairment was evaluated according to the NIHSS in all patients at hospital admission, and at days 1, 2, 3, 15 and day 90 after ICH onset. Multivariate stepwise logistic regression was applied to identify predictors of neurological impairment 90 days after hospital admission.
RESULTS: A total of 821 patients were enrolled; 638 survivors were evaluated with the NIHSS at day 90. Mean NIHSS score at admission was 13.2 (SD 6.6), decreasing to 9.6 (SD 7.7) at day 15 and 5.1 (SD 5.5) at day 90. Twenty-five percent of patients had severe neurological impairment (NIHSS ≥ 15) at baseline compared to 6% of those alive at day 90. Neurological worsening within the first 72 h (defined as worsening of GCS of two or more points or increase in NIHSS score ≥ 4) predicted greater neurological impairment at day 90 in all models. A decrease of <10% in systolic blood pressure (SBP) within the first 24 h was significantly associated with less severe neurologic impairment compared to more severe reductions.
CONCLUSION: Neurological deterioration within 24 h of ICH onset is a powerful determinant of persistent neurological impairment. Careful reduction of the SBP by 1–10% in the first 24 h may lower the risk.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976257     DOI: 10.1007/s12028-011-9632-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  17 in total

1.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

Authors:  S M Davis; J Broderick; M Hennerici; N C Brun; M N Diringer; S A Mayer; K Begtrup; T Steiner
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

Review 2.  A critical appraisal of stroke evaluation and rating scales.

Authors:  P D Lyden; G T Lau
Journal:  Stroke       Date:  1991-11       Impact factor: 7.914

3.  Assessing the outcome of stroke: a comparison between MRI and clinical stroke scales.

Authors:  J Nuutinen; Y Liu; M P Laakso; J O Karonen; R Roivainen; R L Vanninen; K Partanen; L Østergaard; J Sivenius; H J Aronen
Journal:  Acta Neurol Scand       Date:  2006-02       Impact factor: 3.209

Review 4.  A reappraisal of reliability and validity studies in stroke.

Authors:  L D'Olhaberriague; I Litvan; P Mitsias; H H Mansbach
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

5.  Prediction of functional outcome after stroke: comparison of the Orpington Prognostic Scale and the NIH Stroke Scale.

Authors:  S M Lai; P W Duncan; J Keighley
Journal:  Stroke       Date:  1998-09       Impact factor: 7.914

6.  Relationship between 3-month National Institutes of Health Stroke Scale score and dependence in ischemic stroke patients.

Authors:  Karen C Johnston; Douglas P Wagner
Journal:  Neuroepidemiology       Date:  2006-08-22       Impact factor: 3.282

7.  Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee.

Authors:  Thorsten Steiner; Markku Kaste; Markku Katse; Michael Forsting; David Mendelow; Hubert Kwiecinski; Istvan Szikora; Seppo Juvela; Andrzej Marchel; René Chapot; Christophe Cognard; Andreas Unterberg; Werner Hacke
Journal:  Cerebrovasc Dis       Date:  2006-07-28       Impact factor: 2.762

8.  Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.

Authors:  M R Frankel; L B Morgenstern; T Kwiatkowski; M Lu; B C Tilley; J P Broderick; R Libman; S R Levine; T Brott
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

9.  Characteristics of the National Institute of Health Stroke Scale: results from a population-based stroke cohort at baseline and after one year.

Authors:  Peter Appelros; Andreas Terént
Journal:  Cerebrovasc Dis       Date:  2003-10-03       Impact factor: 2.762

10.  A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity.

Authors:  P D Lyden; M Lu; S R Levine; T G Brott; J Broderick
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

View more
  4 in total

Review 1.  Management of Acute Hypertensive Response in Intracerebral Hemorrhage Patients After ATACH-2 Trial.

Authors:  Shahram Majidi; Jose I Suarez; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

2.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Edward Tobinick; Nancy M Kim; Gary Reyzin; Helen Rodriguez-Romanacce; Venita DePuy
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

3.  Loss of mural cell-derived laminin aggravates hemorrhagic brain injury.

Authors:  Jyoti Gautam; Lingling Xu; Abhijit Nirwane; Benjamin Nguyen; Yao Yao
Journal:  J Neuroinflammation       Date:  2020-04-06       Impact factor: 8.322

4.  lncRNA H19 Aggravates Brain Injury in Rats following Experimental Intracerebral Hemorrhage via NF-κB Pathway.

Authors:  Shuaidong Mao; Huan Huang; Xianzheng Chen
Journal:  Comput Math Methods Med       Date:  2022-01-15       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.